At the Heart of Innovation

Zywie, a pioneer in cardiovascular diagnostics, combines wearable biosensors with cloud-based analytics for seamless remote cardiac monitoring. This advanced service is powered by the ZywiePro Solution, a comprehensive three-component matrix designed to enhance care and streamline patient management.

The ZywiePro® Solution provides better efficiency and patient care by allowing physicians to view events faster and in greater detail, anytime on any device all backed by a wealth of experience from working with the largest EMR systems in use today.

3 Components

ZywieAI®

ZywieAI® is our proprietary algorithm, FDA Class II cleared technology that analyzes the transmitted data sent from our Zywie monitors to our secure, cloud-based servers. It is highly sophisticated, highly accurate and more efficient in ECG data processing to detect multiple kinds of arrhythmias and various types of electrical impulses of the heart.

Analysis

Receiving analysis from ZywieAI®, our certified rhythm technicians use our cutting-edge ZywieECG app to review data and notify physicians using customizable parameters to any device they choose. This app also allows physicians or staff to create new enrollments, monitor patient activity and interact with the events and/or reports of their patients.

Monitors

Zywie provides a range of monitors designed to meet the diverse needs of both physicians and patients. Our innovative technology allows seamless transitions between Holter, Event Monitor, and MCT modes, streamlining the patient experience by reducing the need for multiple clinic visits.

Our monitors are lightweight and user-friendly, significantly improving patient compliance. With Zywie, enrollment takes less than a minute, and placing the monitor on a patient requires under two minutes—enhancing both efficiency and convenience in clinical settings.

Physician Review

“For Onset & Termination, no more looking at middle of the strips and having to guess how the EKG started. Zywie makes it easier by including onset & termination right on the report – no need to search.”

Detected in
1-7 days

Detected in
8-14 days

Detected in
15-21 days

Detected in
22-30 days

16-28%

Higher Detection

The results are clear — ordering ZywieNano for 30 days yields a higher detection of first AF, pause and ventricular tachycardia when compared to a 14 day monitor.

Establishing the Next Level in Cardiac Monitoring Solutions

Faster Reporting

No more waiting for results. Zywie’s ability to analyze patients' electrocardiograms in real-time allows clinicians to proactively address abnormal heart rhythms before they worsen or become lethal.

Increased Diagnostic Yield

Zywie’s platform identifies more clinically significant rhythms over standard 14-day monitors by capturing the rhythms previously missed between days 15-30.

Streamlined Device Inventory

Ability to utilize a single device for all patients simplifies use for both patients and staff.

High Patient Compliance

All data is collected and transmitted through Zywie’s industry-leading ZywieNano™ patch, an easy-to-wear miniaturized biosensor that increases patient compliance over traditional monitors.

EMR Compatible

Zywie’s interfaces with all major EMR systems reducing paperwork and clinician time.

Zywie’s platform has been shown to increase diagnostic yields and actionable data for providers over standard 14-day monitors by capturing the rhythms previously missed between days 15 to 30.

The Zywie Difference